BETHLEHEM, Pa., May 02, 2017 -- Furthering its efforts to enhancing patient, clinician and environmental safety, B. Braun Medical Inc. will debut ReadyFor800.com at The Oncology Nursing Society’s Annual Conference, May 4-7 in Denver, Colorado. The new online educational resource will focus on the awareness and implementation of the new hazardous drug safety standard, USP <800>.
“These medications can save the lives of patients, but they also pose risk to our healthcare professionals,” said Tom Sutton, Vice President of Vascular Access Systems at B. Braun. “As one of the leading suppliers of Closed System Transfer Devices (CSTDs) in the United States, B. Braun takes responsibility to help nurses and other healthcare workers proactively protect not only their patients, but also themselves and their coworkers.”
ReadyFor800.com details the risks for healthcare personnel and introduces implementation plans and protocols to ensure the best protection possible from hazardous drug exposure. Supported by expert insight, experience, and recommendations, and told from the pharmacy, nursing and management perspectives, ReadyFor800.com is a comprehensive tool for educating staff and colleagues. It provides a blue print to help implement USP <800> in hospital or outpatient facilities.
At ONS 2017, attendees can visit B. Braun booth #925 to experience ReadyFor800.com. Attendees can gain an understanding of the risks involved in the compounding and administering of hazardous drugs, and discuss the steps required for USP <800> compliance with ONS Connect contributing editor Seth Eisenberg, RN, ASN, OCN®, BMTCN™.
About USP <800>
USP <800> was published on February 1, 2016 with an implementation date of July 1, 2018. The chapter describes practice and quality standards for the handling of hazardous drugs, including transport, storage, preparation, and administration, in healthcare settings to help promote patient safety, worker safety, and environmental protection. USP <800> applies to all healthcare personnel – such as pharmacists, technicians, nurses, physicians, physician assistants, home healthcare workers, veterinarians, and veterinary technicians – as well as all facilities associated with the handling of hazardous drugs.
About B. Braun
B. Braun Medical Inc., a market leader in Closed System Drug Transfer Devices, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. The OnGuard® CSTD from B. Braun is designed to help protect healthcare workers within the pharmacy and specifically during nursing administration of hazardous drugs. OnGuard meets the NIOSH, ASHP, and ONS definitions of a CSTD, along with all proposed USP <800> requirements.
To learn more about B. Braun Medical or OnGuard CSTD, visit www.BBraunUSA.com.
Contact: Jason Ford B. Braun Medical Inc. 610.997.4722 [email protected]


Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 



